South Dakota State University

Open PRAIRIE: Open Public Research Access Institutional
Repository and Information Exchange
Electronic Theses and Dissertations
1981

The Effects of Aerosolized Lead on the Immune and
Hematopoietic Systems
A. Nuri Ozkan

Follow this and additional works at: https://openprairie.sdstate.edu/etd

Recommended Citation
Ozkan, A. Nuri, "The Effects of Aerosolized Lead on the Immune and Hematopoietic Systems" (1981).
Electronic Theses and Dissertations. 4046.
https://openprairie.sdstate.edu/etd/4046

This Thesis - Open Access is brought to you for free and open access by Open PRAIRIE: Open Public Research
Access Institutional Repository and Information Exchange. It has been accepted for inclusion in Electronic Theses
and Dissertations by an authorized administrator of Open PRAIRIE: Open Public Research Access Institutional
Repository and Information Exchange. For more information, please contact michael.biondo@sdstate.edu.

THE EFFECTS OF AEROSOLIZED LEAD
ON THE IMMUNE AND HEMATOPOIETIC SYSTEHS

BY
A. NURI OZKAN

A thesis submitted
in partial fulfillment of the requirements for the
degree Master of Science
Major in Microbiology
South Dakota State University
1981

..- - • I"'"U

n A VnT

T

ll

IVERSIT

U

RY

•.

THE EFFECTS OF AEROSOLIZED LEAD

ON THE IMMUNE AND HEMATOPOIETIC SYSTEHS

This thesis is approved as a creditable and independent
investigation by a candidate for the degree, Master of Science, and is
acceptable for meeting the thesis requirements for this degree.

Accep-

tance of this thesis does not imply that the conclusions reached by the
candidate are necessarily the conclusions of the major department.

~obyn/P. Hillam, Ph.D.

7<Date)

Thesis Adviser

Robert L. Todd, Ph.D.
Head, Microbiology Dept.

11

(Date)

ACKNOHLEDGEMENTS

I wish to express my appreciation to Dr. Robyn Hillam for the
extremely helpful advice and guidance during the course of this
academic endeavor and in the preparation of this thesis.

Personal thanks are .extended to Dr. David Hildebrand, Ms. Hazel
Shave, Ms. Linda Lee, and Mrs. Linda Reilly Gergen for their technical
advice and assistance.

I

also wish to acknowledge the special advice and helpful

suggestions of Ms. Karla Booth and Ms. Terry Sharritt.

Lastly but most important, is the deepest gratitude I

feel for my

family, especially my mother, for their moral support and encouragement
during the critical times of my graduate career.

iii

TABLE OF CONTENTS
Page
ACKNOWLEDGEMENTS
TABLE OF CONTENTS
LIST OF TABLES
ABSTRACT OF THESIS
PROPOSED RESEARCH METHODS
OBJECTIVES
STATEMENT OF SIGNIFICANCE

iii
iv
vi
vii
viii
ix
X

INTRODUCTION

1

LITERATURE REVIEl·l

2

1.

Sources and Emissions of Lead

2

2.

Biological Effects of Lead Exposure
2.1.1 Metabolism of Ingested Lead
2.1.2 Metabolism of Aerosolized Lead
2.2 Toxicity of Lead
2.3 Immunotoxic Effects
2.3.1 Cellular Effects
2.3.2 Effects on B-Lymphocyte Activity
2.3.3 Effects on Macrophage
2.3.4 Effects on Acquired Immunity
2.3.5 Effects on Complement Activity

3
3
5
6
7
7
8
9

MATERIALS AND METHODS

9

11

13

1.

Animals and Treatment Design
1.1 Animals
1.2 Experimental Design
1.2.1 Oral Lead Administration
1.2.2 Lead Aerosolization

13
13
13
13
13

2.

Methods
2.1 Immunological Hethods
2.1.1 Immunization
2.2 Procurement and Treatment of Tissues. Blood and Serum
2.2.1 Henatocrit
2.2.2 Total Leukocyte Counts
2.2.3 Differential Blood Counts
2.2.4 Cellulose Acetate Electrophoresis
2.2.5 Direct Hemagglutination
2.2.6 Complement Hemolytic Activity Determination
2.2.6.1 In vitro lead exposure
2.2.6.2 In vivo lead exposure

15
15
15
15
16
16
16
16
17
18
18
19

3.

Biological Assays
3.1 Phagocytic Index
3.2 LDso Determination

19
19
21
iv

Page
4.

Chemical Methods
4.1 Determination of Lead Content in Tissues

20
20

5.

Statistical Analysis

21

1.

Lead Exposure
1.1 Aerosolization
1.2 Oral Exposure

22
22
22

2.

Effects of Lead on the Immune and Hematopoietic Systems
2.1 Hematocrit Values
2.2 Organ to Body Weight Ratio
2.3 Total Leukocyte Counts
2.4 Differential Cell Counts
2.5 Cellulose Acetate Electrophoresis
2.6 Direct Hemagglutination
2.7 Complement Hemolytic Activity
2.7.1 In vltro Lead Exposure
2.7.2 In vivo Lead Exposure

22
22
22
24
24
26
28
28
31
31

3.

Biological Assays
3.1 Phagocytic Index
3.1.1 Phagocytic Index of Orally Exposed Lead Groups
3.1.2 Phagocytic Index of Aerosolized Lead Group
3.2 LDso Determination

34
34
34
34
36

4.

Chemical Methods
4.1 Atomic Absorption Spectrophotometry

39
39

RESULTS

DISCUSSION

41

1.

Effects of Lead on the Immune and Hematopoietic Systems
1.1 Hematocrit
1.2 Organ to Body Weight Ratios
1.3 Total and Differential Leukocyte Counts
1.4 Cellulose Acetate Electrophoresis
1.5 Direct Hemagglutination
1.6 Complement Hemolytic Activity
1.6.1 In vitro lead exposure
1.6.2 In vivo lead exposure

41
41
41
43
43
44
45
45
46

2.

Biological Assays
2.1 Phagocytic Index
2.2 LDso Determination
2 .3 Lead Concentration in Tissues

47
47
48
49

so

Summary
LITERATURE CITED

52

APPENDIX

57
v

LIST OF TABLES
Page
Table 1.

Organ to Body Weight Ratios

26

Table 2.

Differential and Total Leukocyte Counts

28

Table 3.

Effect of Lead on Serum Proteins

29

Table 4.

Hemagglutination Titers of the Orally Lead Administered
Group and Control Group

31

Hemagglutination Titers of the Aerosolized Lead
Administered Groups and Controls

32

Table 6.

Inhibition of Complement Induced Hemolysis by Lead

34

Table 7.

Hemolytic Complement Activity

36

Table 8.

Phagocytic Index and Peritoneal Macrophage Harvested

38

Table 9.

Phagocytic Index and Alveolar MacrophaBe Harvested

39

Table 5.

Table 10. Results of Lethal Dose 50

40

Table 11. Lead Concentration in Tissue and Blood

43

vi

ABSTRACT OF THESIS

"The Effects of Aerosolized Lead
on the Hematopoietic and Imnrune Systems"

The immunological responsiveness of two groups of mice exposed to
2.5 mg/m3 aerosolized Pb(N03)2 either since birth or for 14 days prior
to immunization were compared with mice receiving equivalent quantities Pb(N03)2 (125 ~g/mouse/day) by gastric intubation for 1~ days.
Each group was immunized at 5 weeks of age with 108 sheep red blood
cells to examine both primary and secondary antibody responses.

Lead

immunotoxicity was evaluated by comparing total and differential
leukocyte counts, cellulose acetate electrophoretic serum profiles,
phagocytic index, hemolytic complement activity, hemagglutination
antibody titers and organ (lung,
body weight ratios.

thyr.~~us,

spleen, kidney and liver) to

Atomic absorption spectrophotometry was used to

determine the concentration of lead in serum, blood and tissues.

None

of the immunological parameters examined were significantly affected
by lead ingestion.

However, aerosolized lead resulted in significant

decreases in antibody titers; hemolytic complement activity; phagocytic indices; thymus to body and spleen to body weight ratios; and
reduced numbers of monocytes as well as a neutrophilic shift to
lymphocytes.

Effects were greatest in mice born and reared in the

aerosolization chamber.

These results indicate the greater immuno-

toxicity of aerosolized lead compared with ingested lead and thus the
daily health hazard aerosolized lead presents.

vii

PROPOSED RESEARCH METHODS

The goal of this research -.;-ras to compare the chronic immunological
effects of aerosolized lead with that of injested lead.
An outbred strain of Swiss Webster mice originally obtained from
Charles River Laboratories was used throughout this project.

Each

litter was sexed, distributed equally among groups, and crossfostered.

The effects of chronic aerosolized lead exposure were

determined using mice exposed either for 14 days or since birth to
aerosolized lead in an aerosolization chamber.

Mice which received

orally administered lead received an equivalent amount of lead by
gastric intubation for 14 days.
control groups.

Both groups of mice had separate

Since the immune and hematopoietic systems are

extremely sensitive to chemical toxi.city, immunological alteration was
deemed to be an effective means of measuring the potential pollutant
health hazards caused by lead.
The parameters used to determine iummunological effects included:
1) total and differential leucocyte counts; 2) hematocrit values;
3) serum profile determinations using cellulose acetate electrophoresis; 4) antibody levels produced against sheep red blood cells;
5) measurement of hemolytic complement activity; 6) LDso determinations after intraperitoneal challenge with Salmonella typhimurium;
7) phagocytic indices of both alveolar and peritoneal macrophage;
8) liver, lung, thymus, spleen and kidney to body weight ratios; and
9) atomic absorption spectrophotonetric determinations of the lead
concentrations in the above mentioned organs.

viii

OBJECTIVES
The objective of this study was to assess the potential immunetoxic effects of aerosolized lead.

This research compared the chronic

immunological effects of aerosolized lead with that of ingested lead
and determined that aerosolized lead at a subclinical level has a more
deleterious effect on both the immune system and the hematopoietic
system than does ingested lead.

ix

STATE~ffiNT

OF SIGNIFICANCE

Lead is a stable chemical element yet it is one of the most insidiously toxic metals known to man.

The cumulative biological effects

of environmental lead pollution present a significant hazard to all
aspects of life.

This danger should be a concern for the health

scientist and the environmentalist, as well as for the agriculturist
and urban dweller.
I

There are two natural pathways for lead to enter the body, inhalation and ingestion.

Aerosolized lead is mobilized into the atmosphere

as a result of the high temperature combustion of fossil fuels and
exists largely as inorganic lead particles of variable size.

Some of

these particles are small enough to allow for deep penetration into
the pulmonary system while the larger particles are cleared by pulmonary cilia and ultimately swallowed.

Lead ingestion can occur during

the consumption of tinned foods or grains and dairy products contaminated with urban dusts.
The major emphasis of previous lead toxicity studies dealt with
the effects of maternal lead ingestion on fetal development and the
effects of ingested lead on children.

These investigations dealt with

extreme lead toxicity resulting in miscarriages and neurological
problems caused by high doses of lead.

Only recently have the more

subtle changes caused by low levels of lead concentration been
investigated.

Since the immune system is very sensitive to environmental
pollutants, it provides an excellent means by which to study the
effects of subclinical lead intoxication.
X

INTRODUCTION

The toxicity caused by ingestion of lead has heen a concern for
man throughout history.

Only recently with the introduction of the

industrial revolution has the need arisen to monitor the effects of
subclinical lead exposure on human health.
Recent investigations on the subtle effects of subclinical lead
toxicity have revealed ultra-structural changes such as the formation

'

of inclusion bodies and metabolic changes such as reduced respiratory
ability and inhibition of enzymatic activity.

The ability of lead to

mimic the metabolism of calcium can interfer with skeletal development, inhibit calcium dependent enzymes and replace calcium at calcium
dependent membrane receptor sites.
Previous studies have demonstrated that ingestion of subclinical
amounts of lead can lead to suppression of antibody synthesis,
increased susceptibility to endotoxin and alterations in the phagocytic ability of macrophages.
Since previous research has concerned itself primarily with the
study of ingestion of substantial quantities of lead, the following
research - has been conducted in an effort to understand the consequences of lead inhalation on health.

Immunological impairment was an

effective means of measuring the potential health hazards caused by
lead due to the extreme sensitivity of the immune and hematopoietic
systems to chemical toxicity.
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LITERATURE REVIEW

1.

Sources and Emissions of Lead
The extreme toxic effects of lead have been known for many years.

Until recently, researchers have been concerned primarily with the
clinical manifestations of severe lead toxicity on both the nervous
and hematopoietic systems.

With increased industrialization and

motorized vehicle activity, and the subsequent increase of lead in the
environment, emphasis is now being placed on the more subtle effects
of lead.

One active area of study is the imrnunotoxicity produced by

lead (8).
Two major pathways exist for the entry of lead into the body:
ingestion and inhalation.

The primary route is ingestion; for

example, the consumption of tinned foods containing high concentrations of lead (8).

The Environmental Protection Agency (18) has esti-

mated that the daily dietary intake of lead by human males
100 to 500

~g

Pb/day.

rang~s

from

In the United States the incidence of lead

poisoning by ingestion is alarmingly high; in 1969, 727 documented
cases of lead poisoning were reported in New York City alone (8, 24).
The majority of the ingested lead is in the elemental form and is
rapidly excreted.

Children afflicted with pica, resulting from the

ingestion of paints containing lead chromate, account for a large percentage of the reported lead poisonings.

Unlike the majority of

ingested elemental lead which is rapidly eliminated, lead chromate is
readily a bsorbed and stored by the body.
Particulate lead, contained in the exhaust gases of combustion
engines, is the other major source of lead pollution.

Levels of par-

ticulate lead are monitored by the Environmental Protection Agency

3

(18).

The acceptable level of atmospheric lead, as determined by the

EPA, is not to exceed 2 ~g Pb/rn3.

However, lead levels much higher

than the acceptable standard have been recorded.
hours in Los Angeles,

Fishbein~

tions as high as 71.3 ~g Pb/rn3.

During peak traffic

al (20) reported lead air concentra-

This particulate lead exists largely

as inorganic lead particles which vary in size.
ticulate lead is small enough (0.18 - 0.9

~m)

Much of the par-

so as to allow for deep

and rapid penetration into the pulmonary system (8, 18, 24).

Larger

particles are cleared by the mucocilliary escillator and ultimately
swallowed.

2.

Biological Effects of Lead Exposure
2.1.1

Metabolism of Ingested Lead
The metabolism of inorganic lead depends upon a

of intrinsic factors.

These factors include:

n~1mber

dietary calcium, sex,

and the types of tissue involved.
Low levels of dietary calcium have resulted in increased lead
absorption due to the competitive nature between lead and calcium (4).
Lead replaces calcium at enzyme receptor sites via a chelating type
effect (donor-acceptor).

This binding appears to be principally a

covalent type bonding rather than ionic (18).
Barry~

lead.

al (5) have shown that sex influences the metabolism of

No n-occupationally-exposed adult males have 30% higher lead

levels (164.8 mg) in both bone and soft tissue than do adult females
(103.6 mg).

With occupational lead exposure the total mean lead body

burden increased to 566.4 mg in adult males.

4

Lead levels vary considerably depenrling upon the type of tissue;
for example, lead levels in the aorta are generally 20 times higher
than those in the muscle.

Using a modified graphite tube furnace

technique, Schlick et al (49) determined lead concentrations of various tissues.

They found that approximately 100 mg of orally admini-

stered lead acetate/kg body weight/day was the threshold dose required
for a long-term increase in tissue Pb concentration.

However, after

30 days treatment, neither the threshold dose nor . 10 times this dose
was sufficient to elevate the blood lead concentration, indicating
rapid clearance of lead from the blood.

Within three days after

intravenous (IV) injections of a subclinical dose of lead, blood lead
levels returned to control levels.
More than 90% of the total lead body burden in adults is immobilized in bone; the remaining lead is localized in soft tissue • . The
Schlick study revealed that the concentration of lead in the soft
tissues (liver and kidney) returned more slowly to normal than did
blood lead levels but that lead bone content remained elevated for an
extended period of time.

Schlick

~

al interpreted the data to indi-

cate that the soft tissue function as an intermediate storage area,
whereas the bone acts as a long term depot.

The subclinical concen-

tration of lead used in the Schlick study has been shown capable of
producing functional disorders of the reticulo-endothelial system,
inhibitio n of the enzyme responsible for heme synthesis (ALA-d) and
neurophysiological alterations.

Since these disorders occur without

producing elevated blood lead levels, the determination of blood lead
level alone, may be inadequate for reliable measurement of lead accumulation (13, 14, 49, 50, 57).

5

Similar experiments using monkeys yielded comparable results (57).
The mechanism and pathway of lead mobilization during pregnancy were
determined by Keller and Doherty (30).
stered Pb in their drinking water.

Pregnant mice were admini-

Results indicate that lead was

primarily sequestered in maternal bone but that during gestation small
amounts were also transferred directly to the fetus.

During lactation

lead was mobilized and subsequently transferred to suckling pups.
Using these results as a model of lead mobilization, they concluded
that approximately 5 mg lead would be transferred during the period of
human lactation.

2.1.2

Metabolism of Aerosolized Lead
Whereas approximately 10% of ingested lead is absorbed,

nearly 48% of inhaled lead is absorbed (12).

The ultimate fate of

inhaled particulate lead is dependent upon a number of physical and
chemical factors which include:

solubility, diffusibility, protein

binding capabilities, chemotactic ability and size of the particle

(11, 29, 1, 45).
Chamberlain et al (12) reported that after a 50 hour post aerosolization period of lead (0.5 ~m), 48% of the initial lung burden had
been transferred to the blood.

Excretion in fecal material after in-

halation was very slight, indicating that only a small amount of lead
was cleared by the pulmonary cilia and swallowed.

Renal clearance was

extremely high and histological changes in tissue could readily be
seen.
Kehoe (29) reported that at low lead air concentrations a large
portion of the particles trapped in the upper respiratory tract
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with lead toxicity.

Anemia . is associated with both severe lead intox-

ication as well as mild environmental lead exposure (41, 55).

Lead-

induced anemia is due to the inhibition of the enzyme delta aminolevulenic acid dehydratase (ALA-d), a required enzyme for heme synthesis (2).

This impairment may be due to the binding of lead directly

to the enzyme rendering it functionally inactive.
Another example of lead-induced enzyme dysfunction is the binding
of lead to nucleosides.
protein synthesis.

An

This binding results in improper coding for
e~ample

of this type of dysfunction is in the

synthesis of certain enzymes required for oxidative metabolism (9, 22,
23).

2.3

Immunotoxic Effects
2.3.1

Cellular Effects
The effects of lead exposure on cellular viability

and function have only recently been aetermined.

These effects range

from decreased enzymatic activity to lowered cellular replication.
Kussel

~

al (40) demonstrated the effects of lead nitrate on nor-

mal proliferation of cultured cells.

A definite inhibitory effect on

the in vitro growth of a rat liver cell line, neuroblastoma cells and
two glioma cell lines were reported with the addition of 1Q-5M lead
nitrate to the culture medium.
Mitogen-induced lymphocyte proliferation is inhibited with in
lead exposure.

In

~

~

exposure to subclinical doses of lead inhi-

bited the proliferative response of lymphocytes treated with lipopolysaccharide (a B-cell mitogen), purified protein derivative (a T-cell
mitogen) or phytohemagglutinin (aT-cell mitogen) (17, 39, 51).

8

Similarly, Koller and Roan (37) observed that the mixed lymphocyte
culture reaction (MLR) using splenic lymphocytes from mice exposed to
lead orally was not significantly altered.

2.3.2

Effects on B-Lymphocyte Activity
Oral exposure to subclinical doses of lead or cad-

mium resulted in significant impairment of B-cell function.
cell is directly responsible for antibody formation. ·

Tne B-

Koller and

Kovacic (35), using a modification of the Jerne plaque assay, reported
that Swiss Webster mice exposed to subclinical doses of orally administered lead acetate, demonstrated a marked decrease in antibody
forming cells.

Inhibition was evident in both the primary and secon-

dary immunologic response, the primary response being the first immunologic response, composed primarily of IgM antibody; the secondary
response is the memory or anamnestic response where largely IgG is the
predominant antibody.

The greatest impairment was observed on the

secondary (IgG) response.
In a similar study Koller, Exon and Roan (33) reported that lead
administered by gastric intubation or injected intraperitoneally (IP)
in mice stimulated the formation of 19S (IgM) antibody but caused a
notable reduction in 7S (IgG) antibody in splenic lymphocytes.
Faith and Kimmel (19) reported a decrease in B-cell function after
chronic pre- and postnatal oral exposure of low levels of lead acetate
in female CD rats.

The total antibody levels of both the primary and

secondary antibody response were markedly depressed in both
postnatal exposure groups.

pre~

and

9

2.3.3

Effects on Macrophage
Macrophage play a key role in the defense mechanism

of cellular immunity by inactivating and processing foreign particles
and bacteria.

The alveolar macrophage is the single most important

factor involved in the removal of inhaled soluble particles (11, 28,
45, 56).
Exposure to lead has resulted in a number of adverse effects on
macrophage.

Effects of lead exposure on macrophage include such find-

ings as reported by

Bouley~

al (7) who found reduced phagocytic

activity in alveolar macrophage as measured by bacterial clearance and
inactivation of aerosolized bacteria, in mice receiving aerosolized
lead.

Kiminski and co-worker (28) have shown that a high order of

toxicity occurs when pulmonary macrophages are directly exposed
(in vitro) to lead.

Kiminski (28) also found that the reduced

~unc

tional activity of macrophages following lead exposure results in the
inhibition of oxidative metabolism, which is a prerequisite for intracellular bacteriocidal activity.

In addition, Trejo (54) demonstrated

that a single intravenous injection of lead acetate impaired the phagocytic ability of Kupffer cells.

Electron microscopic examination of

alveolar macrophage from mice exposed to aerosolized lead revealed
structural damage to mitochondrial and endoplasmic reticulum which
would alter enzyme synthesis and phagocytic ability (6).

2.3.4

Effects on Acquired Immunity
Numerous investigators have reported that

ex~osure

to lead can result in reduced resistance to certain bacterial and
viral infections.

Specific effects such as decreased antibody

10

production, impaired phagocytic ability and impaired detoxification by
the liver have been reported (6, 7, 26, 35).
Hemphill

~ ~

(25) found that mice injected IP with subclinical

doses of lead nitrate over a 30 day period showed greater susceptibility to IP challenge with Salmonella typhimurium than controls.
Selye (52) found that rats which are ordinarily resistant to certain
bacterial endotoxins were more susceptible to the action of these
toxins when exposed to 1 mg lead acetate/100 g body weight administered IP.
(16).

Similar results were obtained by Cook, Hoffman and DiLuzio

A single IV injection of 2 mg lead acetate/100 g body weight

resulted in an enhanced susceptibility of Charles River rats exposed
to Escherichia coli by IP challenge.
Lowered pulmonary resistance to bacterial infection has been shown
with lead exposure (7).

Mice were administered lead via aerosoliza-

tion until a lung lead burden of 6 mg/mouse was achieved.

Mice were

then challenged with Pasteurella multocida via aerosolization.

Lead-

exposed mice had an impaired immunological response which resulted in
decreased resistance to the challenge bacteria.
Lowered resistance to viral infection in lead exposed animals has
also been documented.

Koller (33) demonstrated an immunosuppressive

effect in rabbits exposed to 2500 ppm lead acetate given in drinking
water for 70 days.
virus.

Rabbits were then immunized with pseudorabies

The antibody titers to the virus, as measured by the serum

neutralization plaque assay, were significantly lower in the lead
exposed animals than in the control animals.

11

2.3.5

Effects on Complement Activity
Complement is one of the most essential non-

specific humoral factors in immunity.

Complement is involved in the

lysis, opsonization and inactivation of cellular, bacterial and viral
antigens.

Should the complement system be impaired, bacterial and

viral virulence would be enhanced.
There are two pathways by.which the lytic ability of complement
may be fully activated.
alternate pathway,

These pathways, the classical pathway and the

diff~r

in the method of initial activation.

The

classical pathway depends upon the operation of nine protein components (C1-G9) after activation by an antigen-antibody reaction.

The

alternate pathway is activated by a C3 convertase, an enzyme which is
triggered by extrinsic agents such as endotoxin or microbial polysaccharides.

C3 convertase activates the alternate complement cascade

starting with complement component C3 rather than C1 as is the case in
the classical pathway.
Decreases in complement activity after exposure to various heavy
metals have been widely reported.

Montgomery ~ al (44) reported that

zinc, copper and manganese at concentrations greater than 100

~

strongly inhibited complement-mediated hemolysis of antibodysensitized sheep red blood cells (srbc).

This inhibition appeared to

be due to the decreased formation of activated erythrocyte-antibodycomplemen t complexes.

This theory was subsequently confirmed by

Yamamoto and Takahashi (58) who found that both zinc and copper ions
prevented formation of an active terminal complex ·by inhibiting C9
binding.
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In a similar study Montgomery, Chvapil and Zukoski (43) reported
the in vitro effects of a wide range of zinc chloride concentrations
(25 -500

~M)

on the activity of both free and cell-bound components of

guinea pig complement.

It was shown that all components were found to

be inhibited by super-physiological concentrations of zinc ()100

~M).

In order for inhibition to occur, the addition of zinc had to be as a
third reactant directly rather than addition after complement was cell
bound.

In addition, zinc did not cause irreversible denaturation of

any component of complement.

Studies by Muller-Eberhard

~~

(46)

have shown that zinc and cadmium can block C2 activation, thereby terminating the complement cascade at an early stage in the classical
pathway and disrupting lysis.

13

MATERIALS AND METHODS

1.

Animals and Treatment Design
1.1

Animals
An outbred strain of Swiss Webster mice originally

obtained from Charles River laboratories was used in this study.
Animals were obtained from a breeding colony at South Dakota State
University, Department of Microbiology.

Food (Mouse Chow #5015

Ralston Purina) and water were supplied ad libitum throughout all the
experiments.
Unless stated otherwise, Pb exposures began when the mice were
14 days of age.

Litters were sexed, randomly distributed into groups

of 10 mice, and cross-fostered.
1.2

Experimental Design
1.2.1

Oral Lead Administration
The lead ingestion group was administered lead

orally via gastric intubation using a 1A cc graduated glass tuberculin
syringe (Becton-Dickinson) and a balled bio-medical animal feeding
needle (Perfekturn, Inc.).
dosage of 125

~g

The lead ingestion group received a daily

lead nitrate (Pb(N03)2) in 0.1 cc deionized water.

Control mice received an equivalent quantity of deionized water.
Animals we re treated for 14 days.
1.2.2

Lead Aerosolization
The lead aerosolization study contained two groups.

The first group was placed into the aerosolization chamber at 14 days
T

.J

7 (') ., 0,"
1

,/

I

(/

I

~niiTH

DAKOTA STATE U IV

STY Ll

ARY

14

of age.

The second group was born and reared in the chamber.

chamber design was similar to that described by Arvik

~

The

al (3).

The

exposure chamber consisted of an ILE glovebox with an exhaust filter
fan.

Filtered air (air was from our "air valve") and a solution of

1000 ppm Pb(N03)2 were forced through a nebulizer producing a liquid
aerosol which was blown into a heated desolvation chamber.

The spray

entering the chamber was flash evaporated to produce water vapor and
particulates composed primarily of lead.
cooled to approximately 8°C.

This passed into a condenser

The larger dry particles of lead were

removed by collision. with the walls of the condenser spiral. - The
smaller sized particles passed through the spiral and entered the
exposure chamber via a short piece of tygon tubing.

Controls for this

portion of the study remained outside the chamber.
Mice were exposed to aerosolized lead for 14 days in the case of
the two week old mice and four weeks in the case of the mice born and
reared in chamber.
Both groups were exposed to 2.5 mg Pb(N03)2/m3 or approximately
80 11 g Ph/mouse/day.

This value was determined using data on the lung

volume capacity and respiration rate of mice (47).
It was determined with the use of an Andersen Cascade Impactor
that 81% of the lead entering the chamber was of size <2 microns,
allowing for deep penetration into the pulmonary system.
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2.

Methods
2.1

Immunological Methods
2.1.1

Immunization
Sheep red blood cells from the same sheep and

obtained no later than 7 days prior to immunization were used for all
injections.

Whole sheep blood was collected by jugular venipuncture

in sterile 2 liter Erlenmeyer flasks containing 40 ml of 40% sodium
citrate.

After collection the srbc were transferred to sterile screw

cap bottles and stored at 4°C.

For injection the erythrocytes were

washed three times in 0.85% saline and diluted to the desired
concentration.
After fourteen days of treatment, and at four weeks after birth in
the case of the chamber born mice, each group of mice was injected
intraperitoneally (IP) with 108 srbc in 0.25 cc sterile saline.

On

day 18, half of each group was anaesthetized with ether and terminated
by exsanguination and cervical dislocation.

The remaining mice were

reinjected as previously described on days 18 and 22 and terminated on
day 25 to determine the anamnestic or secondary immune response.
2.2

Procurement and Treatment of Tissues, Blood and Serum
Mice were anaesthetized with ether prior to exsanguina-

tion.

Blood was collected by severing the subclavian artery.

A

sample of blood was allowed to clot for approximately 1 hour at room
temperature.

Using a wooden applicator stick, the clot was removed

from the walls of the glass tube and dried for lead determinations.
The serum was clarified by centrifugation and frozen until needed.
Blood samples for total leukocyte counts, differential white blood
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cell determinations and hematocrits t-Tere also taken.

After termina-

tion the mice were weighed and the thymus, lung, liver, kidney and
spleen were removed, weighed and stored frozen in plastic vials for
lead analysis by atomic absorption spectrophotometry.

2.2.1

Hematocrit
Heparinized microhematocrit capillary tubes were

filled with whole mouse blood and centrifuged in an Adams Hematocrit
centrifuge to determine the percentage volume of erythrocytes.

2.2.2

Total Leukocyte Counts
Forty microliters of whole mouse blood from each

mouse were added to separate disposable blood dilution vials containing 20 ml of Isoton II diluting buffer (Co.ulter Diagnostics, Inc.).
Five drops of Zap Isoton II were addea to lyse erythrocytes.

Le~ko

cyte counts were made on a Model F Coulter Counter (Coulter
Electronics).

2.2.3

Two separate counts were taken, averaged and corrected.
Differential Blood Counts
Blood smears were made using a 3" x 1" bev-1-edge

micro slide and stained in Cameo Quick Stain using the recommended
procedure.

A total of one hundred leukocytes was counted and dif-

ferentiated into monocytes, lymphocytes and neutrophils.
2 .2.4

Cellulose Acetate Electrophoresis
Cellulose acetate electrophoresis was performed to

determine the relative proportion of the major serum components.
Titan III cellulose acetate strips (Helena, Inc.) were submerged in
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Electro HR electrophoresis buffer, pH 8.6 - 9.0 (Helena, Inc.), until
saturated.

An aliquot of 2 pl serum was applied to one end of a strip

using a sample applicator.

The slides were electrophoresed at 180V

for 30 minutes at room temperature.

The slides were stained in

Ponceau S stain for 5 minutes, and destained in 3 consecutive baths of
5% acetic acid.

Clearing of the strips was accomplished by submerging
I

them in a Sepra Clear II cellulose acetate clearing solution .and
heating in an 80°C oven until clear.

The relative proportions of the

major serum components were measured using a planimeter to determine
the area of each component peak obtained from densitometer scans of
the strips.

2.2.5

Direct Hemagglutination
All sera were tested for the presence of anti-srbc

IgG and IgM antibodies using direct hemagglutination.

These tests

were performed using a modified microtiter assay similar to that of
Stavitsky (53).

The assay was performed in 96-well conical bottom

microtiter plates (Linbro).
following manner.

All samples were run in duplicate in the

Normal rabbit serum (1:100) in phosphate buffered

saline (PBS), pH 7.4, was added to each well of the microtiter plate.
The serum to be tested was added to the first well of each row and
two-fold dilutions were made through the eleventh well using a microdilutor (the twelfth well contained only PBS).
an equal volume of 2% srbc suspension was added.

To each of the wells
After a two to four

hour room temperature incubation, the results were recorded.
Agglutination due to both IgG and IgM was obtained using 1:100 NRS
in PBS as the diluent.

Agglutination due to IgG antibody was
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determined using a 1:100 NRS-PBS diluent containing 0.2
toethanol.

~1

beta-mercap-

Beta-mercaptoethanol is a reducing agent which selectively

cleaves the disulfide bridges in the IgM molecule, leaving the IgG
molecule functional.

Titers were reported as the reciprocal of the

last dilution showing any agglutination.

A negative result was indi-

cated by a "button" of nonagglutinated cells.

2.2.6

Complement Hemolytic Activity Determination
To determine the effect of in vivo and in

vitr~

lead exposure on the hemolytic activity of complement, the following
assay was performed.

2.2.6.1

In vitro lead exposure
Reconstituted whole guinea pig complement

(C') (BBL) was used throughout this procedure.

The optimal con-

centration of complement, as determined by the SO% endpoint method of
Burrell (10), was 5 CHso units.

Two units of whole hemolysin (2H')

(BBL) were used as the optimal hemolysin concentration for the sensitization of sheep erythrocytes.
Lead solutions used in the assay were lead acetate, lead chloride
and lead nitrate diluted in isotonic saline at concentrations ranging
from 25 ~M to 400 ~M.

All samples were assayed in triplicate.

Hemolytic assays were conducted by mixing in a clean 12 x 75 mm
glass tu b e 1.5 ml of the test solution, 0.5 ml of the hemolysin solution containing 2 whole H' units, 0.5 ml 2% srbc, and 0.5 ml complement containing 5 CHso units.

The mixture was incubated at 37°C for

30 minutes with frequent agitation.

After incubation the tubes were
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centrifuged for 5 minutes and the optical density of each supernatant
was measured at 541 nm to determine the amount of oxyhemoglobin
released.

The percent hemolysis was calculated by using the following

formula:
Absorbance 541 nm of test sample
Absorbance 541 nm of 100% hemolysis control

2.2.6.2

X

100

In vivo lead exposure
Blood from 8 mice receiving aerosolized

lead for 2 weeks and 8 control mice was collected in pre-chilled test
tubes and placed immediately in an ice bath until clotted.

Serum was

obtained as previously described and assayed the same day to avoid
loss of C' activity.

A mixture consisting of 150

~1

of a 1:2 dilution

of the serum in pH 7.3 verona! buffered saline (VBS), 0.5 ml hemolysin
containing 3 H' units diluted in VBS, 0.5 ml 1% srbc, and 1.85 ml of
VBS were added to clean 12 x 75 mm glass test tubes and vortexed.
Samples were then incubated at 37°C for 30 minutes with frequent
shaking.

After incubation the tubes were centrifuged and the optical

density of the supernatant was measured at 541 nm.

To correct for any

hemolysis present in the mouse serum itself, 150 ~1 of a 1:2 dilution
of serum was brought up to 3 ml in VBS and the optical density
measured and subtracted from the final absorbance of the test sample.

3.

Biological Assays
3.1

Phagocytic Index
The phagocytic index was performed to evaluate the

~ vitro phagocytic ability of both the alveolar and peritoneal
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macrophage.
Alveolar macrophages were harvested in the following manner.

In

order to prevent trauma to the lung, mice were euthanized by injecting
0.3 ml of a 1:10 dilution of sodium pentobarbital (64 mg/ml).

The

trachea was exposed and a 16-gauge 2.5 inch Catholon IV Catheter
Placement Unit (Jelco Lahs, Inc.) was inserted between the tracheal
rings and secured.
sterile saline.

The lungs were lavaged using three 1 ml washes of

The thoracic region was massaged externally for

approximately 3 minutes prior to saline withdrawal and lavage fluids
pooled.

An average of 2.5 ml of lavage fluid was routinely obtained.

Alveolar macrophages were sedimented by centrifugation at 400 g for
15 minutes at room temperature and resuspended in 1 ml of medium 199,
Hanks base (BBL) supplemented with 20% heat-inactivated rabbit serum.
Viability and cell numbers were determined by the trypan blue exclusion method (Appendix A).
Peritoneal macrophages were harvested by washing the abdominal
area with ethyl alcohol and carefully exposing the peritoneal sac.
Three milliliters sterile saline were injected into the peritoneal
cavity, massaged for 2 minutes and removed.
repeated and the peritoneal washes pooled.

This procedure was
The macrophages were then

sedimented, resuspended and counted as previously described.
The technique used for the phagocytic index was a modification of
the procedure used by Gardner~ al (21).

Fluorescent yellow 0.8 ~m

diameter polystyrene latex beads (Dow Chemical) were added to obtain
an 18:1 latex sphere to macrophage ratio.

The samples were incubated

in a 37°C water bath for 30 minutes with frequent agitation. Following
incubation, two 20 ~1 samples of the cell suspension were placed into
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each of the 2 etched rings of a 3" x 1" fluorescent antibody (FA)
slide, air dried, and fixed in Bouins fixative (Appendix B) for
10 minutes.

Following fixation the slides were washed in 50% ethyl

alcohol for 3 minutes, placed into a 100% xylene bath for 3 hours with
occasional shaking to dissolve the extracellular latex spheres, and
rinsed with 50% ethanol.

Macrophages were stained by placing the

slides in a 0.001% fluorescent acridine orange saline staining solution, pH 10, for 4 to 5 minutes and rinsed.

A drop of Bacto FA Mount-

ing Fluid (Difco, Inc.) was added to the two samples on each slide and
covered with a Fisher brand 2 x 2 mm #1 coverslip.

The number of

ingested beads was counted using a Leitz Dialux UV scope with mercury
cathode using the 40X and oil immersion objectives.

The phagocytic

index was calculated using the method of Carpenter (10).

The number

of latex beads phagocytized by ten macrophage from each mouse was used
to determine the phagocytic index of each exposure group and respective control.
3.2

LD5o Determination
The effect of lead exposure on the susceptibility to

bacterial challenge was determined by the intraperitoneal injection of
serial dilutions of a 12-18 hour culture of Salmonella typhimurium
into mice receiving subclinical amounts of lead.

Mice were weighed

and evenly distributed among groups according to weights in a random
fashion.

Six mice were injected with each dilution.

dead mice per dilution was recorded daily for 1 week.

The number of
The LD5o, .stan-

dard error and 95% confidence limits were calculated by the method of
Irwin and Cheeseman (27).
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4.

Chemical Methods
4.1

Determination of Lead Content in Tissues
Lead content in blood, serum, spleen, liver, lung and

thymus was analyzed by atomic absorption spectrophotometry using a
modification of the procedure used by

Christian~

al (15).

Following

initial drying at room temperature, the previously collected tissue
samples were dry-ashed at temperatures not exceeding 500°C.

The

spleen, lung lobe, thymus and blood samples were prepared as whole
samples.

Due to the mass of the liver and kidney, it was necessary to

grind and weigh a portion of the sample being analyzed.

Each sample

was added to a 30 ml Kjedahl flask rinsed with 3 N hydrochloric acid.
To each flask was added 5 ml of double distilled nitric

acid.

The

mixture was boiled until approximately 2 ml of the nitric acid remained, at which time 250

~1

of perchloric acid and 2-3 ml of nitric

acid were added and boiled to near dryness.

The sample was solubi-

lized by adding 1 ml of deionized water to the flask, heating and then
transferring it to a 5 ml volumetric flask and bringing it up to
volume.
Atomic absorption spectrophotometric analysis was performed using
a Perkin Elmer model 503 AA spectrophotometer using argon as the
carrier gas.

The temperature and time settings were 30 seconds drying

time at 150°C; 50 seconds charring time at SSOoC; and 7 seconds atomizing time at 2300°C.

The wavelength setting used was 283.7 nm, and

the lead cathode was set at 10 rnA.

Parts per million lead was deter-

mined using a standard curve of 0.05, 0.1, and 0.15 . ppm lead
solutions.

All test samples and controls were run in triplicate.
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5.

Statistical Analysis
All statistical analyses were performed with a Texas Instrument 58C

calculator.

Data were evaluated by the one way analysis of variance.

Levels of significance are reported at the 99 and 95% levels.
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RESULTS
1.

Lead Exposure
1.1

Aerosolization
The level of lead nitrate used for aerosolization was

2.5 ~g/m3 as determined using an Anderson Cascade Impactor.

Using the

lung volume and respiration rates for mice (47), it was determined
that each mouse was inhaling approximately 80 ~g Pb/day.

At the lead

concentration used, no overt clinical symptoms of lead toxicity were
observed.

1.2

Oral Exposure
The level of oral lead exposure was chosen to correspond

to the concentration of lead received by the lead aerosolized mice.
The oral dosage of lead was 125

~g

Pb(NOJ)2/mouse/day.

The two

natural exposure routes of lead were compared to respective controls
and to one another to assess the most immunotoxic route of exposure.

2.

Effects of Lead on the Immune and Hematopoietic Systems
2.1

Hematocrit Values
Neither the oral lead exposed group (Pboral), the two

week aerosolized lead group (Phair), nor the chamber born group (Pbch)
had significantly different hematocrit values when compared to control
group Coral (deionized HzO gavage) and Cair (non-aerosolized).

Since

clinical lead toxicity has been shown to result in major hematocrit
changes, the dosage of lead administered in this experiment was of a
subclinical level.

25

2.2

Organ to Body Weight Ratio
Organ to body weight ratios were performed to determine

the effects of lead on specific lymphoid organs (Table 1).
Of the five organs compared (lung, kidney, liver, thymus and
spleen) in the orally lead ingested group, no significant differences
were seen.
In group Pbair highly significant decreases in organ to body
weight ratios occurred in the thymus and spleen samples when compared
to controls.

In addition, a highly significant increase in the organ

weight ratio of the kidney occurred in this group.
Organ to body weight ratios which occurred in group Pbch when come
pared to controls included highly significant decreases in spleen and
liver samples, with a highly significant increase in the kidney to
body weight ratios.

2.3

Total Leukocyte Counts
Total leukocyte counts were determined to assess the

effects of subclinical ~ ~ lead exposure on white blood cells
(WBC).

The results are shown in Table 2.

The totat WBC count in

group Pboral did not differ significantly from the oral control group
receiving deionized water.

The two week lead aerosolized group also

had similar cell counts compared to the non-aerosolized control group
Cair•

A highly significant reduction was observed in group Pbch when

compared to control group Cair•

The longer lead exposure together

with the cumulative nature of lead might account for the reduction in
white blood cells.

Table 1
Organ to Body Weight Ratios
Of Mice Exposed to Pb by Ingestion or Inhalation&

Group
Orally Fed Control (Coral)

(%} Liver/Body

(%} Kirlney/Body

(%) Thymus/Body

(To) Spleen/Body

1.48

0.40
± .o s

0.62

6.28

± .OR

± .34

± .07

(%) Lung/Body
0.97
± .os

Orally Fed Lead {Pboral>
(75 llg Pb/day)

1.46

0.38

0. 6 2

6 .68

0.94

± .fl7

± .08

± .26

± .24

± .06

Non-aerosolized Control
(Cair)

1.43
± .07

0. 39
± .07

0. 62
± .25

7.48

0.96

± .92

± .11

Aerosolized Lead {Pbatr>
(80 l!g Ph/day)

1 . 63
± .o7b

0.27
± .o7h

0.46

6.91

0.96

± .o6h

± .60

± .10

Chamber Born (Pbch)
( 80 l!g Pb/ day)

± .19b

0.31
± .04

0.41
± .o7h

5. 76
±.6oh

±.0.7

1.9

1.05

a Mean ± S.D.
b p < 0.01 as determined by the Analysis of Variance method
c Ten mice were observed in each dosage group.

I'V
(J)
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2.4

Differential Cell Counts

-- ----

To determine changes in cell populations due to in vivo

exposure to subclinical amounts of lead, differential cell counts were
done.

The results of the cell counts are listed in Table 2.

No

significant differences were observed between groups Pboral and
controls Coral•

Comparing lead aerosolized groups Pbair and Pbch to

controls Cair, a neutrophilic shift to lymphocytes was observed.

A

significant reduction in monocytes also occurred in group Pbair•
2.5

Cellulose Acetate Electrophoresis
Changes in serum globulins due to lead exposure were

measured by cellulose acetate electrophoresis and are reported in
Table 3.

.The serum profiles for group Pboral were similar to Controls

Coral, indicating no alterations in the serum proteins with this route
of exposure.

Serum profiles of the two week lead aerosolized group

when compared to nonaerosolized controls, indicated a significant reduction in the gamma globulin peak.

The gamma region is the electro-

phoretic region which contains antibody.

The other electrophoretic

regions (albumin, alpha and beta globulins) were within normal range.
In group Pbch a highly significant decrease in the gamma globulin
region was noted as well as a decrease in the beta globulin peak, when
compared to controls Cair•

The beta globulin region contains notable

serum proteins such as plasminogen, fibrinogen, complement components,
activators and inhibitors.

The albumin region in group Pbch increased

to a highly significant degree to compensate for the decreases in
gamma and beta globulins.

The reduction in the gamma globulin region

Table 2
Differential and Total Leukocyte Counts
Of Mice Exposed to Lead by Ingestion and InhalationC

{%)
Group

{%)

Lymphocyt~~-- -~~---___B~~t:~_Qphils

{%)
Honogte

Total Leukocyte

Orally Fed Control
(Coral)

73.3 ± 4.9

19 . 5 ± 2.5

7.2 ± 2.1

1 7 , 6 33 ± 58 R7 / ml

Orally Fed Lead
(Pb 0 ral) (75 pg Ph/day)

70.6 ± 8.4

23.2 ± 6.6

6.2 ± 4.4

16 , 2 7 5 ± 2 31 0 I ml

Non-aerosolized Control
(Cair)

70.6 ± 5.4

23.2 ± 4.1

6.2 ± 2.2

19,840 ± 9354lml

Aerosolized Lead
(Phair) (80 llg Ph/day)

79.8 ± 3.8a

15.8 ± 3.2a

4.4 ± 0.9a

19,950 ± 8227 lml

Chamber Born
(Pbch) (80 llg Ph/day)

86.3 ± 3.4a

10.2 ± 3.2b

3.5 ± 0.8

16 , 4 7 5 ± 3 768 I ml a

a
b
c
d

p < 0.05 as determined by the Analysis of Variance method
p < 0.01 as determined by the Analysis of Variance method
Mean ±S.D.
Ten mice were observed in each dosage group.
N

co

Table 3
Selected Effect of Lead on Serum Proteins
In Lead Exp osed Mi cec

(%)

(%)

tAlph~

Beta

( ~)

•r

(%)
Gamma
:::~eO

2"0

/,Jj :::: Z"4

2.1 .. 4

60o0 :i: 6 .. :..

11.3 ± 4,.2

"/1):1 -:: 4 .. 0

210)2 ± 4. 9

Non-aeros olized Co nt rol

56el ±

)&fj

lO .. A :::

z. q

7. 6 ± 2. 0

25 . 9 ± 4.1

Aerosolized Le ad
(80 ~g Pb/day)

59 . 9 ± 4 .. 8

1L.9 ±

Z~2

8 . 6 ± 3.3

19 . 6 ± 3.7a

Chamber Born
( 80 ~g Pb/ day)

67 . 9 ± 2 . sb

10 . 5 ± 2. 4

5. 1 ± 1.3b

16.5 ± 2.2b

Ora lly Fed Cont rol

62 .. 6 ± 4.1

Oral ly Fed Le ad
(75 ~g Pb/day)

[} .. 4

..<:

a p < o.os as determined by the Analysis of Variance method
b p < 0.01 as determined by the Analysis of Variance method
c Mean ±S.D.
d Ten mice were observed i~ each dosage group.

N

\0
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in both lead aerosolized groups is the first indicator in this study
that the subclinical concentration of lead used is imm1nosuppressive
when inhaled.

Furthermore, it appears that with longer lead exposure,

as with group Pbch, additional alterations in serum globulins can
occur.
2.6

Direct Hemagglutination
The direct hemagglutination test (HA) combines high

degrees of both sensitivity and specificity in measuring antibody to a
specific antigen.

The immunogen used in this study was srbc, which is

both a T- and a B-c e ll immunogen.

To differentiate the IgG antibody

response from total antibody (IgG and IgM), S-nercaptoethanol was
used.

Hemagglutination titers for the orally ingested lead group

(Pb 0 ral) were similar to control group Coral receiving deionized
water.

This was the case for both the primary and secondary immunolo-

gic responses.

These results compare favorably with the serum profile

results for this group in respect to the 'normal' level of gamma globulin of group Pboral•

With lead aerosolization, the HA titers for

the primary immunologic response of both groups Phair and Pbch showed
a highly significant decrease compared to controls Cair•

The primary

immunologic response is mainly due to 19S (IgM) antibody as determined
with the use of S-mercaptoethanol.

The HA titers for the secondary

immunologic response in the two week lead aerosolized group Pbair rose
to an equivalent titer as the control group Cair for both total (IgG
and 1~1) and 75 (IgG) antibody.
marily to IgG antibody.

The secondary response is due pri-

Secondary immunologic HA titers for group
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Table 4
Hemagglutination Titers of Mice
After Pb Ingestion

Group

Total Antibodya
and
95% Confidence Beta-mercaptoethanol
Intervals
resistant (IgG)

Orally Fed Control: primary
response

96 (73-115)

<4

Orally Fed Control: secondary
response

2048 (1536-2816)

96 (81-105)

Orally Fed Lead: primary
response
( 7 5 llg Pb I day)

96 (80-122)

Orally Fed Lead: secondary
response
( 7 5 llg Pb I day)

2048 (1536-2816)

<4

128 (112-144)

a Titers expressed as the geometric mean.
b Ten mice were observed in each group, five for the primary response
and five for the secondary response.
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Table 5
Hemagglutination Titers of Mice
Exposed to Aerosolized Lead

Group

Total Antihody
and
95% Confidence
Intervals

Non-aerosolized Control:
primary response

192 (164-282)

Non-aerosolized Control:
secondary response

256 (172-289)

128 (92-165)

32a (22-40)

4 (3.5-5)

Two week Aerosolized
Lead: primary response
(30 1-Jg Pb/day)
Aerosolizerl Lead:
secondary response
(80 ~ Pb/day)
Chamber Born:
primary response

192 (163-229)

Beta-mercaptoethanol
resistant (IgG)

8 (6-8.5)

128 (91-143)

16a (15-18)

not performed

64a (51-73)

32a (30-40)

( R0 ll£ P b Ida y)

Chamber Born:
secondary response
( 8 0 llg P b Ida y)

a p < 0.01 as determined by AOV
b Ten mice were observed in each group, five for the primary response
and five for the secondary response.
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Pbch compared to Cair remained significantly suppressed in both total
antibody and IgG antibody.

2.7

Complement Hemolytic Activity
The measurement of hemolytic complement activity is a

widely used assay which serves as a convenient quantitative method to
identify decreased complement activity.

2.7.1

In vitro Lead Exposure
The three lead compounds tested in the in vitro

portion of the hemolytic complement assay were lead acetate, lead
chloride and lead nitrate.

All of the lead compounds were inhibitory

on hemolytic complement activity.

The degree of inhibition was depen-

dent upon the concentration of lead added.

The levels of inhibition

(Table 6) are typical of the type of inhibition caused by a number of
other heavy metals on complement activity.

As we observed at levels

) 100 ~M, lead inhibition was produced up to the highest concentration
of lead used.

> 300

Inhibition values for lead nitrate at concentrations

~M could not be obtained due to the lytic effects of higher con-

centrations of this compound on sheep erythrocytes.
For all compounds tested at concentrations less than 100 ~M, no
inhibition was observed.
To determine whether a competitive reaction existed between lead
and calcium-magnesium, various concentrations of calcium-magnesium
saline were added to the lead solutions prior to incubation with srbc.
The final concentrations of calcium-magnesium used were 1000, 800,
500, 400 and 200 ~M solutions.

Inhibition of all lead compounds
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Table 6
Inhibition of Complement Induced Hemolysis by Leada

Lead Solution Used
A.

Lead Nitrate

2 50
200
150
100

B.

ll H
llM
ll 11
ll H

75.4
19.2
1.5
1.5

Lead Acetate

400
3 50
300
2 50
200
150
100

c.

Percent Inhihition

].lH
ll H
ll M
ll H

J.lH
ll H

J.lM

90.0
89.0
86.5
13.1
10.0
4.4
1.5

Lead Chloride

400
350
300
250
200
150
100

J.lM
J.lH
].lM
11M
11M
11M

11H

87.0
85.5
63.2
27.5
4.4
2.5
2.5

a All solutions prepared in isotonic saline
solution.
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tested was reversed with the addition of a calcium-magnesium saline
solution twice the molarity of the lead solution causing inhibition.

2.7.2

In vivo Lead Exposure
Results of the hemolytic C' activity in sera of

mice exposed to aerosolized lead for two weeks are shown in Table 7 ,
along. with serum lead values.

A 1:2 dilution of serum was used to

measure the hemo-lytic complement levels of both a lead aerosolized
group and a nonaeroso-lized control group.

Activity of complement in

serum was reduced to a highly significant degree (approximately 12%)
in the lead exposed group compared to controls.

The average serum

lead content as determined by AAS for the two week lead aerosolized
group (1.49 ppm) was ten times higher than that of the controls (0.147
ppm).

3.

Biological Assays
3.1

Phagocytic Index
To determine the effects of lead exposure on the phago-

cytic ability of peritoneal and alveolar macrophage (M~), a phagocytic
index was determined on ingested and aerosolized lead groups and their
respective controls.
3.1.1

Phagocytic Index of Orally Exposed Lead Groups
The phagocytic index (PI) of both peritoneal and

al veo 1 ar

M~

~

group Coral•

i n group Pb ora did not differ significantly from control
1
The number of alveolar and peritoneal M~ harvested i"rom

the orally exposed lead group was
cytes harvested from the control.

also similar to the number of phageResults of the PI and number of
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Table 7
Hemolytic Complement Activity .o f Serum
After In Vivo Exposure to Aerosolized Pb

Group

Average Serum Lead Concentration

Average
Percent Hemolysis

Control
(Non-aerosolized)

0 • 14 4 ± 0 • 0 0 7 ppm

92.5 ± 5. 3

Two Week Lead
(Aerosolized)

1.485 ± 0.07 ppma

so.5a±

a p

< 0.01

7.6
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cells harvested are given in Table 8.

With the results obtained thus

far it appears that with lead ingestion at the subclinical levels used
in this experiment, much of the lead entering the body is rapidly eliminated and excreted, thus allowing for normal phagocytic ability of
both alveolar and phagocytic macrophage.
3.1.2

Phagocytic Index of Aerosolized Lead Group
The phagocytic index for the peritoneal

M~

of

groups Pbair, Pbch and the control group Cair is given in Table 8.
Inhalation of lead at the quantity and duration as used in this
experiment did not appear
peritoneal macrophage.

to effect the phagocytic ability of the

The quantity of cells harvested froo the lead

exposed mice was also comparable to numbers of cells harvested from
the respective controls.

It appears therefore that the peritoneal

M~

does not contribute to the immunosuppressive effect elicited by lead.
The major cellular effect of aerosolized lead appeared to be on
the alveolar macrophage of both groups Pbair and Pbch•

As the results

in Table 9 indicate, a highly significant decrease in the PI was
observed when compared to the control group Cair•

The number of

alveolar M~ recovered from both aerosolized lead groups was 3.5 times
the number of cells recovered from the non-aerosolized controls.

3.2

LDso Determination
orally lead exposed mice and two week lead aerosolized

mice along with controls for each group were challenged IP with
Salmonella typhimurium to determine the LDso.

The LDso results are

given in Table 10, along with the standard error and confidence
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Table 8
Phagocytic Index of Peritoneal Macrophages Harvested
By Saline Lavage in Lead Exposed Mice

Group

Phagocytic Index

Harvested Cells
(cells/ml)

Control Groupb

2.3 . ± 0.66

1.45x106 ± 1. 5x106

Orally Fed Leadb
(75 llg Pb/day)

1.9

±0.45

1.72x106 ± 8.5x105

Two Week Lead Aerosolizedb
(80 ll& Pb/day)

2.2

± 0.57

2 .23x106 ± 1.0x106

Chamber Bornb
(80 llg Pb/day)

2.7

±0.93

1.46xl06 ± 6.8x105

a Mean ten mice/group ± S.D.
b The number of fluorescent beads in ten macrophage per slide were
counted to determine the phagocytic index.
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Table 9
Phagocytic Index of Alveolar Macrophages Harvested
By Lung Lavage in Lead Exposed Mice

Group

Phagocytic Indexc

Harvested Cells
(cells/ml)

----------------~~----

Control Groupb

6.1 ± 0.68

1.4xlo5

± 4. 7:·do4

Orally Fed Leadb
(75 llg Pb/day)

5.6 ± 0.63

2 .3xlo5

± 1.6xlo5

Two Week Lead Aerosolizedb
(80 llg Pb/day)

4.3 ± 0.75C

5 .lxlo5 ± 1.4xl05c

Chamber Bornb
(80 llg Ph/day)

4.5 ± 0.89C

6.3xlo5 ± 1.4xlo5c

a Mean ten mice/group ± S.D.
b Ten macrophage/mouse were counted for phagocytic index.
c p < 0.01 as determined by one way AOV.
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Table 10
Results of Lethal Dose 50
In Lead Exposed Mice
Using the Organism Salmonella typhimurium

Group

LDso and 95% Confidence Intervalsa

3.31xl05 CFU/mouse
(4.3xl04 ~ 2.Sxl06)

Orally Fed Control

Orally Fed Lead (75

~g

Non-aerosolized Control (80

Aerosolized Lead (80

~

1.89xlo5 CFU/mouse
(2.3xlo4 - 9.4xl05)

Pb/day)

~g

Pb/day)

Pb/day)

2.02xl08 CFU/mouse
(1.2xl08 - 8.0xl08)
1.57xl06 CFU/mouse
(2.4xl05 - 9.9xl06)

a Irwin-Cheeseman (27) method used to determine 95% confidence levels.
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intervals as determined using the method of Irwin and Cheeseman (27).
In the ingested lead group, Pb 0 ral, similar

LDso

values were obtained

as for control group Coral, indicating no impairment of the immune
system.

In group Pbair a 128-fold difference in the

when compared to the

LDso

LDso

for the nonaerosolized controls.

was seen
It would

appear that aerosolized lead does alter the immune system causing an
immunosuppressive effect, when a gram negative organism is injected.

4.

Chemical Methods
4.1

Atomic Absorption Spectrophotometry
Subclinical quantities of lead which are ingested are

rapidly eliminated from the body, as reported previously.
appears to be the case in this study.

This

Of the five organs measured for

lead content, only the kidney indicated an increase in lead content
compared to controls Coral•

As a two-fold increase was observed in

this group, these results compare favorably with results obtained by
Koller ~ al. (33) who also reported increased kidney lead content
with ingestion of subclinical amounts of lead in mice.
Inhalation of lead resulted in a greater retention with accumulation of lead in the kidney, liver, lung, thymus and serum.

In group

Pbair, the kidney lead content was raised nearly four fold over the
control group Cair•

In addition, a highly significant increase in

liver lead content and lung lead content was observed, as well as a
significant increase in serum lead content when compared to the
control group.

Significant increases in the thymus, . liver and lung
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lead contents of group Pbch was observed compared to controls Cair•
The spleen and blood lead levels did not differ significantly from
controls in either of the aeerosolized lead groups.

Table 11
Lead Concentrations in the Tissues and Blood
Of Mice Exposed to Ingested or Aerosolized PbC

Group

-------------------------- Mean parts per million Leadd ----------------------- -Thymus
Spleen
Liver
Lung
Kidney
Blood

Orally Fed Control

20.1 ± 7.9

16.2 ± 9.1

29.7 ± 11.3

9.7 ± 5.9

11.9 ± 4.6

3.8 ·± 1.0

Orally Fed Lead

14.3 ± 8.2

17.9 ± 12.4

31.0 ± 9.7

8.2 ± 1.5

21.5 ± 5.8a

4.7 ± 2.4

Non-aerosolized Control

21.2 ± 10.0

14.8 ± 5.6

22.4 ± 5.4

6.2 ± 0.79

12.0 ± 5.0

3.6 ±1.0

Two Week Aerosolized Lead

32.2 ± 13.6

39.5 ± 18.8

63.3 ± 12.6b

54.9 ± 35.88

43.8 ± 13.9b

4.9 ± 3.8

Chamber Born

43.9 ± 16.2a

43.1 ± 28.5

53.9 ± 23.08

101.8 ± 66.08

50.4 ± 12.2b

5.5 ± 2.5

a
b
e
d

p < 0.05 as determined by the Analysis of Variance method
p < 0.01 as determined by the Analysis of Variance method
Mean of 10 mice± S.D.
Results reported as parts per million lead in organ dry weights

+

w
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DISCUSSION

The effects of toxic substances have been evaluated by parameters
such as carcinogenicity, teratogenicity, embryogenicity and neurotoxicity.

The study of alterations in immunocompetence by toxic sub-

stances has been greatly neglected in the past.

This oversight may

pose a serious hazard since toxic substances can impair the capacity
for mounting immunological reactions which seriously endangers the
health and life span of both man and animal.

Recently the immuno-

suppressive effects of lead exposure have been assessed using criteria
such as those in this study.

1.

Effects of Lead on the Immune and Hematopoietic Systems

1.1

Hematocrit
Anemia is one of the first clinical indications of lead

toxicity.

Although it is known that anemia occurs with severe lead

intoxication, the threshold blood lead level at which anemia occurs
has not been clearly established (18).

Hematocrit levels as deter-

mined in this study are used as an indicator of anemia.
Hematocrit levels of the lead administered groups were not significantly different from those of control animals.

This result

suggests that a subclinical level of lead was administered in this
study.
1.2

Organ to Body Weight Ratios
Organ to body weight ratios were calculated for lymphoid

organs to determine changes produced by lead exposure.

Animals
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administered lead orally had no statistically significant differences
in organ to body weight ratios compared with control animals.

This

finding is not unusual since 1) the concentration of lead used was of
a subclinical level and 2) a large portion of ingested lead (-90%) is
rapidly excreted from the body (29).
Animals in the lead inhalation group had significant weight
changes in a number of organs.

Animals exposed for two weeks,

Phair , had a highly significant (p
body weight ratio.

< 0.01)

decrease in the thymus to

This decrease was not observed in the chamber born

Pbch group, although a 21% decrease in thymus weight did occur.
Whether the observed thymic atrophy associated with these groups
resulted directly or indirectly in a T-cell dysfunction (31,32) was
not assessed.
The spleen to body weight ratio in both aerosolized lead groups
was decreased significantly (p

< 0.01).

The spleen is associated with

the humoral or antibody mediated immune response, therefore, this
decrease in organ weight could be associated with reported impairment
in B-cell immunity (31,32,33,35).
Hepatic atrophy occurred only in the chamber born group
(p ( 0.01).

The liver serves as a detoxification organ containing a

number of enzymes that are required for endotoxin neutralization which
might account for the enhanced susceptibility previously observed
(52).
Kidney to body weight ratios in both group Pbair and Pbch
increased to a highly significant degree compared with control group
Cair•

Similar increases in kidney weights have been reported by a
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number of investigators (34).

The kidney is also an essential

filtrate organ containing numerous enzymes used in neutralization.
The lung to body weight ratio remained normal in both aerosolized
groups compared with controls.

1.3

Total and Differential Leukocyte Counts
The cytotoxic nature of lead has been clearly demonstrated by

a number of investigators (40) who have shown that extremely low
levels of lead (lo-5 M) can cause cellular death.

This toxicity

appears to involve lysosomes, inclusion bodies and reduced cellular
enzymatic activity.
Alterations in leukocytes may lead to impaired humoral as well as
cellular immune responses, therefore, total and differential leukocyte
counts were performed to.determine any changes in these parameters.
Differential counts as well as total leukocyte counts remained unaffected in the orally administered lead group compared with controls.
Again this is further evidence that a large proportion of the ingested
lead is excreted prior to entering the circulatory system.
Both aerosolized lead groups, Pbair and Pbch, had significant
changes in total and differential leukocyte counts.

A significant

neutrophilic shift to lymphocytes was observed in both groups.
Phair had a significant (p
highly significant (p
a significant (p

< 0.01)

< 0.05)

decrease in monocytes.

< 0.05)

Group

increase in lymphocytes and a

decrease in neutrophils.

Group Pbch had

increase in lymphocytes and a significant
Both monocytes and neutrophils serve as phago-

cytic cells, and a decrease in both cell types may lead to lowered
bacterial clearance and decreased cellular immunity.
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1.4

Cellulose Acetate Electrophoresis
Through cellulose acetate electrophoresis the major globulins

found in serum can be separated and quantitated to determine changes
in these globulin fractions.

The serum globulins are separated into

four basic groups; albumin, alpha globulins, beta globulins and gamma
globulins.
Sera obtained from the orally lead administered group indica t ed no
abnormalities in globulin fractions compared with control sera,
whereas both aerosolized

~ead

groups had reduced globulin fractions.

The gamma globulin fraction which contains the majority of immunoglobulins was reduced by 24% in group Pbair and by 36% in group Pbch•

In

addition, the beta globulin fraction containing complement associated
proteins and blood clotting factors was reduced to a highly significant level in group Pbch ()40% reduction).

The albumin level in - this

group increased 17% to compensate for the reductions in gamma and beta
globulin levels.
A reduction in antibody levels as well as immunoglobulin synthesis
with lead exposure have been previously reported (8,16,18,25,31-38,

42).

A major finding thus far in this study is that significant immu-

nosuppression has been established with exposure to lead at levels
considered subclinical and in quantities approaching levels found in
urban centers.

1.5

Direct Hemagglutination
To measure the overall competence of the immune system a

direct hemagglutination assay was performed on experimental and
control animals.

The direct hemagglutination assays both T and B cell
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function and combines high degrees of sensitivity and specificity
using sheep red blood cells as the antigen.
Titers for group Pboral were comparable to control Coral•

These

results were in agreement with the serum profiles obtained for this
group discussed in the previous section.
Both aerosolized groups (Phair and Pbch) had highly signifiqantly
lowered primary antibody responses for IgM (19S) antibody compared
with control Cair•
The secondary response of the two week lead aerosolized group was
comparable to that of the control group, whereas the secondary antibody response in group Pbch remained significantly (p

< 0.01)

suppressed.
These data correlate with the results of the electrophoretic serum
profiles which indicated reduced gamma globulin fractions.

Whether

impairment in antibody synthesis is due to dysfunction in the T-cell
orB-cell populations was not established.

Koller and Kovacic (35),

who reported lowered antibody response to srbc in mice exposed to 1300
ppm lead acetate administered orally, suggested the specific impairment was due to T-helper cell dysfunction.

This fact as yet has not

been conclusively established.

1.6

Complement Hemolytic Activity
Complement refers to a group of interacting serum proteins,

many of which are capable of enzymatic activity.

Complement was ori-

ginally detected by its ability to cause cytolysis of antibody sensitized (bound) bacteria and erythrocytes.

It is now clear that
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complement mediates a number of additional reactivities other than
cytolysis, such as opsonization and chemotaxis (43,44).
Eleven complement proteins have been identified in the usual antibody initiated hemolysis; these comprise the classical pathway.

A

number of these components require calcium for their integrity and for
reactivity.

The most calcium dependent is the Cl complex, consisting

of three proteins, Clq, Clr and Cls, linked together by calcium (10).

1.6.1

In vitro lead exposure
Our data on the effects of three lead compounds on

complement activity indicated that lead at concentrations )100
duced a profound inhibitory effect on hemolysis.

~M

pro-

The amount of inhi-

bition to hemolytic complement activity was concentration dependent
with the greatest inhibition observed at the highest lead concentration ()300

~M).

Lead nitrate levels )300

~M

caused a lytic effect and

therefore inhibition could not be determined.

(100

~M

At lead concentrations

no noticeable inhibitory effects occurred.

These results are

comparable to those obtained for other heavy metals which produced
inhibition of hemolytic complement activity (43,44).
This inhibitory effect was found to be reversible with the addition of Ca-Mg saline at twice the concentration of the lead solution
which caused inhibition.

It is therefore apparent that lead inter-

feres with the binding of components either by 1) causing a separation
of the Cl complex through replacement of Ca by Pb, 2) replacing
calcium at receptor sites which may require

calcium~

or 3) replacing

calcium required for the enzymatic action of specific complement
components.
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1.6.2

In vivo lead exposure
Hemolytic complement activity in mice exposed to

aerosolized lead for a two week period was inhibited 12% compared with
normal non-aerosolized controls.

These results are similar to those

obtained by Montgomery et al. (44) in which zinc glycine injected
intravenously in rabbits at two to three times the physiological serum
zinc concentrations resulted in significant inhibition of total C'
activity in sera of treated rabbits.
Lead serum levels determined by atomic absorption in group
Phair mice revealed a 10-fold increase in Pb compared to nonexposed
controls.

This is unusual since the majority of lead was found to be

contained in serum rather than in the blood clot containing the red
blood cell portion.

2.

Biological Assays
2.1

Phagocytic Index
Phagocytosis serves a critical role in the clearance of

foreign substances.

Bacteria, viruses and foreign particles are

readily eliminated by specific phagocytic cells, generally macrophages

(M0).

Three major groups of M~ exist, the alveolar macrophage found

in the lungs, the Kupffer cells found in the liver and the peritoneal
macrophages located in the peritoneum.

The phagocytic activity of the

alveolar and peritoneal macrophages were measured in this study.
Lead administered to mice via gastric intubation caused no impairment of phagocytic activity in either alveolar or peritoneal macrophage.

The number of M0 harvested froo each area was equivalent to
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the number harvested from control group Coral•

These data are not

unusual in that other parameters measured up to this point for group
Pboral have resulted in no statistically significant changes, indicating rapid clearance of ingested lead.
In both aerosolized lead groups (Pbch and Pbair) the phagocytic
index (PI) and number of M~ harvested from the peritoneal cavity

ere

equivalent to those obtained from control group Cair•
A 21% decrease in the PI of alveolar

M9

resulted in groups Pbair

and Pbch, whereas, the number of alveolar }10 collected from these
groups was 3.5 times the number harvested from group Cair•

Impaired

phagocytic ability was anticipated in this group for the following
reasons:

1) lead suppressed humoral antibody formation;

~)

lead

nitrate injected intraperitoneally impaired Kupffer cell phagocytosis
(54); and 3) bacterial clearance was impaired following lead instillation (7).

The increase in the number of cells harvested from the

lungs was an unusual finding in that a number of investigators have
clearly demonstrated the cytotoxic property of lead and other heavy
metals on

M0

(6,7,11,28,36,45).

It appears that much of the inhaled lead enters the pulmonary
system and subsequently inhibits the phagocytic activity.

Whether

this inhibition is due to impaired enzymatic activity produced by lead
as suggested by Kaminski (28) or whether lead produces a proliferation
of immature phagocytes as Bouley (7) suggests has not been determined.
Although a large quantity of lead enters the hematopoietic system with
inhalation, at the concentration used it is evident that lead does not
reach the peritoneal

Mf

or that these phagocytes are less sensitive to

the cytotoxic effect of lead.
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2.2

LD5o Determination

Decreased immunologic reactivity at both the humoral and cellular levels has been shown to occur with lead exposure.
whether acquired immunity is impaired in
as reported

~

To determine

following lead exposure

by Hoffman (26), Hemphill (25) and Selye (52),

LD50 determinations using Salmonella typhimurium were performed.
Results for the LD5o obtained for group Pboral were similar to
those obtained for controls Coral•
vious results for this group.

This finding correlates with pre-

Dysfunction of the immune system was

not evident in this group suggesting lead ingested at the quantity
used in this group was rapidly excreted and eliminated.
Inhalation of lead resulted in very large differences in the LD5o
value.

A 128-fold decrease in LD5o titer occurred in group

Phair~

Possible factors responsible for this decrease are the following:
1) antibody levels were reduced; 2) phagocytic activity of specific

M~

was inhited; 3) complement activity was reduced; or 4) liver enzyme
function was impaired resulting in decreased endotoxin neutralization
(16,26).

All of the previously mentioned factors alone or together

can easily account for the increased mortality seen in the lead aerosolized group.

These results further demonstrate our observations

that inhaled lead poses a greater health hazard than previously
determined
2.3

Lead Concentration in Tissues
A rapid elimination of lead occurs after ingestion, as is

evident from

ato~c

absorption spectrums obtained from various tissue
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samples.

Only the kidney had elevated (p

Pb 0 ral compared with controls.

< 0.05)

lead levels in group

This is not an unusual finding; Koller

et al. (33) reported elevated kidney lead levels in mice administered
lead orally.

It is interesting to note that no impairment was ob-

served for any of the parameters measured in this group; in addition,
lead levels in blood, serum, liver, lung, spleen and thymus all

~

re

of a normal level, again indicating rapid elimination of ingested
lead.
Inhalation of lead resulted in elevated lead tissue levels in all
organs with the exception of the blood and spleen.

This is unusual

because antibody formation (due to B-lymphocytes found in the spleen)
was decreased.

The findings that lead levels in the spleen were nor-

mal and normal peritoneal M~ function was observed suggest that circulating lead may not reach this area to any great extent.

If this is

the case, the B-lymphocyte may not be responsible for the reduction in
antibody to srbc and Salaonella typhimurium.
the predominant cell type affected by lead.

The T-lymphocyte may be
These data also indicate

the need for improved monitoring of lead levels other than blood
levels, since these were found to be comparable to controls.

Similar

findings were reported by Schlick (48) who reported normal blood lead
levels in exposed animals.

Since serum lead levels were found to be

greatly elevated (10%) in the aerosolized lead group, monitoring of
sera rather than whole blood may prove a more sensitive indicator of
lead exposure.
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Summary
At the subclinical dose of lead administered in this investigation
it has become apparent that the route of exposure plays a critical
role in the imrnunotoxic effects produced by this element.
lead resulted in little or no adverse immunotoxic effects.

Ingested
The same

quantity of lead, when inhaled resulted in suppression of both
mediated and humoral immune responses.

ce~l

Observed cellular effects

included a reduction of monocytes, decreased phagocytic activity of
alveolar macrophage and decreases in neutrophils leading to an
increase in the lymphocyte population.

Humoral suppressive effects

seen were decreased antibody levels, increased susceptibility to bacterial infection, lowered antibody titers to T and B cell immunogen
and decreased hemolytic complement activity, both in vivo and
in vitro.

Other observed effects included elevated lead levels in

liver, lung, spleen, thymus and serum.

These changes all occurred

without indication of anemia (normal hematocrit), suggesting subclinical exposure to lead.
It was also observed that blood lead levels (clotted blood) were
not elevated from any of the exposed groups using atomic absorption
spectrophotometry.
(48).

Si~lar

results have previously been reported

This finding further demonstrates the need for a more sensitive

method for determining exposure to lead compounds.
With the results reported in this study it has been demonstrated
that lead exposure poses a significant health hazard which could lead
to lowered ability to resist infection, as well as lower the immunosurveillance mechanism thereby increasing the chance of neoplasia.
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Appendix

Trypan Blue Dye Solution (Stock)

A.

Trypan Blue
Distilled Water

1 g

100 ml

(Working)
Trypan Blue (Stock) 1 ml
Isotonic Saline
9 ~1

B.

Bouins Fixative
Picric Acid, saturated aqueous
Formalin
Glacial acetic acid

75 ml
25 ml
5 ml

